Funding for this research was provided by:
National Natural Science Foundation of China (82173170, 82103089)
Science and Technology Research Program of Chongqing Municipal Education Commission (KJZD-K202000405)
Received: 13 December 2021
Accepted: 22 March 2022
First Online: 29 March 2022
: The study was authorized by the Ethics Committee of Chongqing Medical University and performed in accordance with the Declaration of Helsinki. Written informed consents were obtained from all patients. All the animal experiments were approved by Chongqing Medical University Animal Care and Use Committee.
: All authors give consent for the publication of the manuscript in Molecular Cancer.
: The authors declare that they have no competing interests.